Plasma sterilization has emerged as a revolutionary approach for medical device manufacturing, offering effective sterilization without toxic residues or harmful byproducts. Unlike EtO and formaldehyde which can leave toxic residues, hydrogen peroxide gas plasma sterilization breaks down into harmless water and oxygen.
The low-temperature plasma process requires less energy to operate, contributing to lower operational costs. It protects both patients and healthcare staff—the plasma step breaks down leftover hydrogen peroxide quickly, releasing less vapor when equipment is opened.
Cold atmospheric plasma (CAP) produces reactive oxygen species (ROS), reactive nitrogen species (RNS), UV photons, and charged particles highly advantageous for biomedical applications. These include wound healing, decontamination, implant surface treatment, dentistry, and even cancer therapy.
Plasma jet devices demonstrate rapid bactericidal effects on common bacteria, fungi, and spores, with average sterilization rates exceeding 99.99%. The indirect cold atmospheric plasma-aerosol (CAP-A) method offers particular promise for thermolabile medical devices, inactivating microorganisms, viruses, yeasts, and biofilms. Plasma-based treatment avoids surface damage associated with conventional methods using heat, chemicals, or radiation.